Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07125937) titled 'Silver Diamine Flouride in Arresting Enamel Caries' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: HITEC-Institute of Medical Sciences
Condition:
Carious Lesion
Intervention:
Drug: 38% Silver Diamine Fluoride
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 7, 2024
Target Sample Size: 250
Countries of Recruitment:
Pakistan
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07125937
Disclaimer: Curated by HT Syndication....